Search alternatives:
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
441
-
442
Vasopressin decreases EPSPs in CA2 after LTP induction.
Published 2013“…<p>A: Top: typical recordings of the combined EPSP/IPSP evoked by stimulation of LIII entorhinal fibers (EC LIII) and recorded in CA2 pyramidal neurons (inset). …”
-
443
-
444
The expression of genes related to mitochondria was decreased in Pgam2 mice.
Published 2013“…Peroxisome proliferator-activated receptor α (PPARα), peroxisome proliferator-activated receptor δ (PPARδ), estrogen related receptor α (ERRα), mitochondrial transcription factor A (Tfam), carnitine palmitoyltransferase 1b (CPT-1b), isocitrate dehydrogenase 3 α (IDH3α), oxoglutarate dehydrogenase (OgDh), succinyl-CoA synthetase α (SCS), mitochondrially encoded NADH dehydrogenase 4 (ND4), alpha-subcomplex 9 of complex I (α-s9), mitochondrial succinate dehydrogenase iron-sulfur subunit (SDHB), iron-sulfur protein (Fe-S), cytochrome b (Cyt-b), cytochrome c (Cyt-c), cytochrome c oxidase subunit VIIa (COX7a), uncoupling protein 2 (UCP2), uncoupling protein 3 (UCP3), and manganese superoxide dismutase (Mn-SOD) levels were decreased in Pgam2 mice. …”
-
445
-
446
-
447
-
448
PKCε activation induces aggrecan gene expression, decreases ADAMTS5, and detection of ADAMTS-5-depended cleavage of ECM aggrecan through upregulation of hsa-miR-377 expression.
Published 2013“…<p>(<b>A</b>) RT-PCR detected the relative expression of ACAN, MKI67, ADAMTS5 after treatment of NP cells with 1 μM ψεRACK (or vehicle) for indicated times and revealed that time-dependent activation of PKCε significantly increased the mRNA expression for aggrecan, while in an opposing manner decreased ADAMTS5; mRNA levels of the proliferation marker Ki67 became barely detectable after 8 hours of PKCε activation. …”
-
449
-
450
-
451
-
452
-
453
-
454
-
455
-
456
Annual number of outpatient visits in all eyes.
Published 2025“…<p>Mean visit frequency (mean ± standard deviation) significantly decreased from 11.5 ± 4.3 preoperatively to 8.8 ± 4.1, 5.0 ± 3.4, and 4.4 ± 3.2 visits in the first, second, and third postoperative years, respectively (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”
-
457
-
458
-
459
Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups.
Published 2025“…CRT in the recurrence group significantly decreased from 546.1 ± 117.0 μm preoperatively to 317.1 ± 46.9, 317.8 ± 55.6, 290.8 ± 33.5, 342.9 ± 82.2, 333.0 ± 84.2, and 349.8 ± 76.9 μm at 1, 3, 6, 12, 24, and 36 months postoperatively, respectively (Kruskal-Wallis test, p < 0.001). …”
-
460